microRNA Profiling Identifies Cancer-Specific and Prognostic Signatures in Pediatric Malignancies
Jun S. Wei(Center for Cancer Research), Javed Khan(Kent State University), Malcolm A. Smith(National Cancer Institute), Peter A. Johansson(AstraZeneca (Sweden)), Christopher L. Morton(St. Jude Children's Research Hospital), Peter J. Houghton(The University of Texas at San Antonio Health Science Center), Adam Cheuk(National Institutes of Health), Young Song(University of British Columbia), Xinyu Wen(National Institutes of Health), Qingrong Chen(National Cancer Institute), Steffen Durinck
Cited by 54
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934